EyeCon 2026 Banner
|Videos|February 4, 2021

Tarsus execs discuss origins, treating Demodex blepharitis

Tarsus Pharmaceuticals's CEO Bobby Azamian, MD, PhD, and Chairman Michael Ackermann, PhD, speak on the development of their company and the latest updates on their lead candidate product to treat Demodex blepharitis.

Latest CME